BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 10623735)

  • 1. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
    Aguirre AJ; Robertson ES
    J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of intertypic recombinants of the Epstein-Barr virus from the body-cavity-based lymphomas cell lines BC-1 and BC-2.
    Aguirre AJ; Robertson ES
    Virology; 1999 Nov; 264(2):359-69. PubMed ID: 10562498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.
    Szekely L; Chen F; Teramoto N; Ehlin-Henriksson B; Pokrovskaja K; Szeles A; Manneborg-Sandlund A; Löwbeer M; Lennette ET; Klein G
    J Gen Virol; 1998 Jun; 79 ( Pt 6)():1445-52. PubMed ID: 9634087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.
    Horenstein MG; Nador RG; Chadburn A; Hyjek EM; Inghirami G; Knowles DM; Cesarman E
    Blood; 1997 Aug; 90(3):1186-91. PubMed ID: 9242551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.
    Spadavecchia S; Gonzalez-Lopez O; Carroll KD; Palmeri D; Lukac DM
    J Virol; 2010 Oct; 84(20):10488-500. PubMed ID: 20686042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.
    Miller G; Heston L; Grogan E; Gradoville L; Rigsby M; Sun R; Shedd D; Kushnaryov VM; Grossberg S; Chang Y
    J Virol; 1997 Jan; 71(1):314-24. PubMed ID: 8985352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.
    Robertson ES; Tomkinson B; Kieff E
    J Virol; 1994 Mar; 68(3):1449-58. PubMed ID: 8107208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
    Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
    J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus Are Maintained Together to Transform the Same B-Cell.
    Sugden AU; Hayes M; Sugden B
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.
    Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV, HHV-8)].
    Katano H
    Uirusu; 2010 Dec; 60(2):237-45. PubMed ID: 21488336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus vectors for gene delivery to B lymphocytes.
    Robertson ES; Ooka T; Kieff ED
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11334-40. PubMed ID: 8876136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.
    McHugh D; Caduff N; Barros MHM; Rämer PC; Raykova A; Murer A; Landtwing V; Quast I; Styles CT; Spohn M; Fowotade A; Delecluse HJ; Papoudou-Bai A; Lee YM; Kim JM; Middeldorp J; Schulz TF; Cesarman E; Zbinden A; Capaul R; White RE; Allday MJ; Niedobitek G; Blackbourn DJ; Grundhoff A; Münz C
    Cell Host Microbe; 2017 Jul; 22(1):61-73.e7. PubMed ID: 28704654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells.
    Nicol SM; Sabbah S; Brulois KF; Jung JU; Bell AI; Hislop AD
    J Virol; 2016 Apr; 90(8):3849-3859. PubMed ID: 26819313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Kaposi's sarcoma-associated herpesvirus stably transforms peripheral B cells towards lymphomagenesis.
    Faure A; Hayes M; Sugden B
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16519-16528. PubMed ID: 31363046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus.
    Arvanitakis L; Mesri EA; Nador RG; Said JW; Asch AS; Knowles DM; Cesarman E
    Blood; 1996 Oct; 88(7):2648-54. PubMed ID: 8839859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus recombinants from overlapping cosmid fragments.
    Tomkinson B; Robertson E; Yalamanchili R; Longnecker R; Kieff E
    J Virol; 1993 Dec; 67(12):7298-306. PubMed ID: 8230453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.